News

Video: Changing focus: Creating deal and business models with faster returns in mind

January 4th, 2012 - Tags: , ,

A few nimble VCs and entrepreneurs are developing funds and corporate structures that may once again make private biotech companies attractive investments. Companies changing the game have one common theme: they focus on the drug, not the company. Moderator Ruediger Herrmann, Partner at WilmerHale, and panelists explore these nascent deal and company structures as well as innovative approaches to rethinking the drug development model.

© 2012 EBD Group AG


Share:
  • email
  • LinkedIn
  • Twitter
  • Facebook
  • Google Bookmarks
  • Yahoo! Bookmarks
  • RSS

Related Posts

  1. Video: Recognizing and avoiding mistakes that can cost you the deal
  2. Video: Inside the deal

Latest Posts

  1. Epizyme: Intensive dealmaking in pursuit of personalized therapeutics
  2. Forma Therapeutics: Structured acquisitions to fix broken biotech model
  3. Foundation Medicine: Molecular information disrupting the oncology universe

Newsletter

Subscribe to partneringNEWS
An online journal for executives in the life sciences, partneringNEWS™ is focused on the people behind the deals. Putting a human face to a collaboration agreement gives business development professionals the ability to get behind the headlines.

Sign up today to the free newsletter and never miss any new content.